FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
    Filters
      Symbols
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan
      Dashboard

      Boehringer, Zealand Obesity Drug’s 13% Weight Loss Disappoints

      Boehringer Ingelheim GmbH’s and Zealand Pharma A/S’s experimental obesity drug survodutide helped patients with diabetes shed as much as 13.1% of their weight, disappointing investors.

      Source: Bloomberg
      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud